Cargando…
Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients
While cardiovascular disease has been associated with an increased risk of coronavirus disease 2019 (COVID-19), no studies have described its clinical course in patients with aortic stenosis who had undergone transcatheter aortic valve replacement (TAVR). Numerous observational studies have reported...
Autores principales: | Kibler, Marion, Dietrich, Laurent, Kanso, Mohamad, Carmona, Adrien, Marchandot, Benjamin, Matsushita, Kensuke, Trimaille, Antonin, How-Choong, Cécile, Odier, Albane, Gennesseaux, Gabrielle, Schramm, Ophélie, Reydel, Antje, Hess, Sébastien, Sato, Chisato, Caillard, Sophie, Jesel, Laurence, Morel, Olivier, Ohlmann, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700222/ https://www.ncbi.nlm.nih.gov/pubmed/33266474 http://dx.doi.org/10.3390/jcm9113769 |
Ejemplares similares
-
Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement
por: Trimaille, Antonin, et al.
Publicado: (2021) -
Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch
por: Matsushita, Kensuke, et al.
Publicado: (2023) -
Impact of Antithrombotic Regimen and Platelet Inhibition Extent on Leaflet Thrombosis Detected by Cardiac MDCT after Transcatheter Aortic Valve Replacement
por: Jimenez, Charline, et al.
Publicado: (2019) -
Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced left ventricular ejection fraction
por: Matsushita, Kensuke, et al.
Publicado: (2020) -
Combination of Primary Hemostatic Disorders and Atrial Fibrillation Increases Bleeding Events Following Transcatheter Aortic Valve Replacement
por: Matsushita, Kensuke, et al.
Publicado: (2023)